Congenital erythropoietic porphyria with erythrodontia: A case report.

BACKGROUND The causes for intrinsic tooth discoloration can be separated into two categories as systemic and local. Systemic causes are either genetic or drug-induced effects. The development of dentition can also be affected by a number of systemic factors and metabolic diseases such as porphyria. Congenital erythropoietic porphyria (CEP), also known as Gunther's disease, is a metabolic disease caused by a transformation in the gene that codifies uroporphyrinogen-3 synthesis, leading to porphyrin aggregation in urine, skin, bone, and dentin. CASE REPORT A 21-month-old girl with erythrodontia was referred to Paediatric Dentistry Department in September 2017. A physical examination revealed blisters on her face, nose, hands, and feet. Laboratory findings showed highly elevated urine total uroporphyrin and total coproporphyrin I and III levels. Next-generation sequencing multigene panel testing for porphyria demonstrated a homozygous c.10C>T (p.L4F) mutation in the UROS gene. For curative therapy, the patient was admitted to the allogeneic bone marrow transplantation program. CONCLUSION Congenital erythropoietic porphyria most commonly presents in the first few years of life. Manifestations can include reddish-colored urine, skin blistering, scarring, and erythrodontia. A timely diagnosis can prevent undesirable skin findings of the disease and death due to hematological involvement before a curative allogeneic bone marrow transplantation is performed.

[1]  M. Lalanne,et al.  Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition , 2017, Human molecular genetics.

[2]  Esther S. Kim,et al.  Afamelanotide: A Review in Erythropoietic Protoporphyria , 2016, American Journal of Clinical Dermatology.

[3]  Policy on the Dental Home. , 2016, Pediatric dentistry.

[4]  J. Abkowitz,et al.  Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria. , 2015, Blood.

[5]  R. Desnick,et al.  The porphyrias: advances in diagnosis and treatment. , 2012, Hematology. American Society of Hematology. Education Program.

[6]  A. Finlay,et al.  A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases , 2012, The British journal of dermatology.

[7]  A. Finlay,et al.  Congenital erythropoietic porphyria: a single‐observer clinical study of 29 cases , 2012, The British journal of dermatology.

[8]  B. Prakash,et al.  Erythrodontia in congenital erythropoietic porphyria , 2011, Journal of oral and maxillofacial pathology : JOMFP.

[9]  S. Koley,et al.  CONGENITAL ERYTHROPOIETIC PORPHYRIA: TWO CASE REPORTS , 2011, Indian journal of dermatology.

[10]  American Academy of Pediatric Dentistry reference manual 2009-2010. , 2009, Pediatric dentistry.

[11]  B. Hamre,et al.  Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  C. Pameijer,et al.  Nonvital tooth bleaching: a review of the literature and clinical procedures. , 2008, Journal of endodontics.

[13]  M. Badminton,et al.  Allogeneic bone marrow transplantation in a 7‐year‐old girl with congenital erythropoietic porphyria: a treatment dilemma , 2007, The British journal of dermatology.

[14]  K. Olthoff,et al.  Sequential Liver and Bone Marrow Transplantation for Treatment of Erythropoietic Protoporphyria , 2006, Pediatrics.

[15]  M. Kooijman,et al.  Oral aspects of porphyria. , 2005, International dental journal.

[16]  K. Astrin,et al.  Congenital erythropoietic porphyria: advances in pathogenesis and treatment , 2002, British journal of haematology.

[17]  M. Badminton,et al.  MANAGEMENT OF ACUTE AND CUTANEOUS PORPHYRIAS , 2002, International journal of clinical practice.

[18]  R. Desnick,et al.  Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation. , 2001, Journal of the American Academy of Dermatology.

[19]  I. Lamrissi‐Garcia,et al.  Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  M. Kletzel,et al.  Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature , 2001, Bone Marrow Transplantation.

[21]  A. Moore,et al.  Acute porphyric disorders. , 2000, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[22]  H. Adami,et al.  Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. , 1999, American journal of epidemiology.

[23]  I. Tezcan,et al.  Congenital Erythropoietic Porphyria Successfully Treated by Allogeneic Bone Marrow Transplantation , 1998 .

[24]  I. Glass,et al.  Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells. , 1998, Molecular genetics and metabolism.

[25]  I. Tezcan,et al.  Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation. , 1998, Blood.

[26]  Fayle Sa,et al.  Congenital erythropoietic porphyria--oral manifestations and dental treatment in childhood: a case report. , 1994 .

[27]  A. Fontanellas,et al.  Salivary porphyrin concentration in porphyria cutanea tarda. , 1993, Journal of dermatological science.

[28]  G. Humphrey,et al.  Long term results of chemotherapy on the developing dentition: caries risk and developmental aspects. , 1988, Community dentistry and oral epidemiology.

[29]  J. Soames,et al.  Effects of Cytotoxic Chemotherapy on Dental Development , 1987, Journal of the Royal Society of Medicine.

[30]  S. N. Gandhi,et al.  Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. , 1987, The New England journal of medicine.

[31]  F. Herbert,et al.  Unusual case of green teeth resulting from neonatal hyperbilirubinemia. , 1987, ASDC journal of dentistry for children.

[32]  W. Berdon,et al.  Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. , 1986, The New England journal of medicine.

[33]  E. Witbeck.  Acute intermittent porphyria: clinical management and report of case. , 1985, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[34]  A. Meyer,et al.  The Anaemia of Erythropoietic Porphyria with the First Description of the Disease in an Elderly Patient , 1965 .